
Quarterly Result12 Nov 2026, 08:02 pm
Eyantra Ventures Declares Standalone Unaudited Q2 FY27 Results
AI Summary
Eyantra Ventures Limited announced its standalone unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results in a meeting held on November 12, 2026. The company was unable to consider consolidated results due to a delay in receiving financials from a subsidiary. The trading window will remain closed until 48 hours after the declaration of consolidated results. The company also noted an investment of INR 1,080 Lakhs in NEURO AND SPINE ASSOCIATES PRIVATE LIMITED and the utilization of proceeds from a preferential issue.
Key Highlights
- Standalone unaudited financial results for Q2 FY27 declared.
- Consolidated results deferred due to subsidiary financials.
- Trading window closure extended.
- Investment in NEURO AND SPINE ASSOCIATES PRIVATE LIMITED noted.
- Preferential issue proceeds utilization detailed.
Price Impact
More from EY